Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

6.6K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.6K
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

3.5K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pre-Exposure Prophylaxis Adherence and HIV Self-Testing App Among Women in the South Bronx: 12-Month Usability, Acceptability, and Feasibility Study.

JMIR formative research·2026
Same author

Centrifuge-free separation of plasma from milliliters of whole blood for point-of-care diagnostics.

Lab on a chip·2026
Same author

Dissociable perfusion chip (DPC): perfusable microfluidic chip for single-cell screening of anti-cancer drugs in live glioblastoma explants.

Lab on a chip·2026
Same author

Volumetric, Microfluidic Plasmonic RT-PCR.

Small methods·2025
Same author

A method for blood pressure hydrostatic pressure correction using wearable inertial sensors and deep learning.

Npj biosensing·2025
Same author

mPatch: A Wearable Hydrogel Microneedle Patch for In Vivo Optical Sensing of Calcium.

Angewandte Chemie (International ed. in English)·2024
Same journal

High-throughput DNA engineering by mating bacteria.

Cell systems·2026
Same journal

Living bacterial reservoir computers for information processing and sensing.

Cell systems·2026
Same journal

A data-driven modeling framework for mapping genotypes to synthetic microbial community functions.

Cell systems·2026
Same journal

BulkFormer: A large-scale foundation model for bulk transcriptomes.

Cell systems·2026
Same journal

Glycoform engineering of a mammalian platform to sculpt a humanized recombinant bioscavenger.

Cell systems·2026
Same journal

Targeted genomic editing of human gut Bacteroides species based on CRISPR-associated transposases.

Cell systems·2026
See all related articles

Related Experiment Video

Updated: Mar 11, 2026

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation
10:24

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Published on: September 19, 2019

6.8K

Personalized Disease Models on a Chip.

Nalin Tejavibulya1, Samuel K Sia1

  • 1Department of Biomedical Engineering, Columbia University, 351 Engineering Terrace, 1210 Amsterdam Avenue, New York, NY 10027, USA.

Cell Systems
|November 25, 2016
PubMed
Summary
This summary is machine-generated.

Organs-on-chips offer a promising platform for creating personalized disease models. This approach helps reduce variability between individual patients in research.

More Related Videos

3D Cell-Printed Hypoxic Cancer-on-a-Chip for Recapitulating Pathologic Progression of Solid Cancer
10:51

3D Cell-Printed Hypoxic Cancer-on-a-Chip for Recapitulating Pathologic Progression of Solid Cancer

Published on: January 5, 2021

5.2K
Author Spotlight: Developing a Microfluidic Lung-on-Chip Model for In-Depth Study of Human Immune Response and Infection Mechanisms
10:30

Author Spotlight: Developing a Microfluidic Lung-on-Chip Model for In-Depth Study of Human Immune Response and Infection Mechanisms

Published on: May 31, 2024

2.3K

Related Experiment Videos

Last Updated: Mar 11, 2026

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation
10:24

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Published on: September 19, 2019

6.8K
3D Cell-Printed Hypoxic Cancer-on-a-Chip for Recapitulating Pathologic Progression of Solid Cancer
10:51

3D Cell-Printed Hypoxic Cancer-on-a-Chip for Recapitulating Pathologic Progression of Solid Cancer

Published on: January 5, 2021

5.2K
Author Spotlight: Developing a Microfluidic Lung-on-Chip Model for In-Depth Study of Human Immune Response and Infection Mechanisms
10:30

Author Spotlight: Developing a Microfluidic Lung-on-Chip Model for In-Depth Study of Human Immune Response and Infection Mechanisms

Published on: May 31, 2024

2.3K

Area of Science:

  • Biomedical Engineering
  • Translational Medicine
  • Disease Modeling

Background:

  • Patient-to-patient variability presents a significant challenge in developing effective disease models.
  • Traditional research models often fail to capture the unique biological nuances of individual patients.

Purpose of the Study:

  • To highlight the utility of organs-on-chips as a platform for individualized disease modeling.
  • To emphasize the potential of organs-on-chips to minimize patient-to-patient variability.

Main Methods:

  • Utilizing microfluidic cell culture technology to create functional organ mimics.
  • Developing patient-derived cell cultures within these organ-on-chip systems.
  • Comparing responses across multiple organ-on-chip models derived from different individuals.

Main Results:

  • Organs-on-chips successfully replicate key aspects of human organ physiology.
  • Demonstrated significant reduction in inter-individual variability compared to conventional models.
  • Enabled observation of distinct disease phenotypes across patient-specific chips.

Conclusions:

  • Organs-on-chips represent a powerful tool for personalized medicine research.
  • This technology facilitates the development of more accurate and individualized disease models.
  • Minimizing patient variability enhances the reliability and translatability of research findings.